Biotech

All Articles

Vaxcyte surges on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what professionals named "spectacular" stage 1/2 information for its 31-valent pne...

Recursion's brain health condition test shows little proof of efficacy

.Recursion has discovered through an early test of its own tech-enabled strategy to medication revel...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Contact it a case of good chemical make up: Acepodia, a biotech based upon Nobel Champion scientifi...

Praxis epilepsy medicine decreases seizures in phase 2 litigation

.Praxis Accuracy Medicines has racked up another midphase gain in epilepsy this year, along with its...

Three officers resign as Dyne posts combined data for DMD prospect

.After leaving a professional grip numerous years back, Dyne Therapeutics has shown brand new stage ...

Arrowhead fires off phase 3 data in uncommon metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand before a possible showdown with Ionis,...

Pfizer, Valneva reveal lyme health condition shot helpful for second booster

.Pfizer and also Valneva may possess concerning two even more years to hang around prior to they mak...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a talk along with Ayla Ellison, Brutal Biotech Editor-in-Chief and Michelle Benz as...

New information demonstrate how Bayer's asundexian failed to prevent movements

.Bayer put on hold the period 3 test for its own variable XIa inhibitor asundexian behind time in 20...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its several sclerosis (MS) med tolebrutinib to the FDA, execs have...